85 related articles for article (PubMed ID: 28736886)
21. Global variation in the pattern of differentiated thyroid cancer.
Woodruff SL; Arowolo OA; Akute OO; Afolabi AO; Nwariaku F
Am J Surg; 2010 Oct; 200(4):462-6. PubMed ID: 20887838
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
[TBL] [Abstract][Full Text] [Related]
23. Minimally invasive follicular thyroid carcinomas: prognostic factors.
Stenson G; Nilsson IL; Mu N; Larsson C; Lundgren CI; Juhlin CC; Höög A; Zedenius J
Endocrine; 2016 Aug; 53(2):505-11. PubMed ID: 26858184
[TBL] [Abstract][Full Text] [Related]
24. [Hürthle cell carcinoma of the thyroid. A 41 years experience].
Sanz J; Cerpa F; Domínguez M; Franco C; Jadresic A; Pérez G; Phillipi V
Rev Med Chil; 1999 Jul; 127(7):821-6. PubMed ID: 10668290
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
Xu B; Ibrahimpasic T; Wang L; Sabra MM; Migliacci JC; Tuttle RM; Ganly I; Ghossein R
Thyroid; 2016 Nov; 26(11):1588-1597. PubMed ID: 27480016
[TBL] [Abstract][Full Text] [Related]
26. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
27. A prospective study of thyroid nodular disease in children and adolescents in western Poland from 1996 to 2000 and the incidence of thyroid carcinoma relative to iodine deficiency and the Chernobyl disaster.
Niedziela M; Korman E; Breborowicz D; Trejster E; Harasymczuk J; Warzywoda M; Rolski M; Breborowicz J
Pediatr Blood Cancer; 2004 Jan; 42(1):84-92. PubMed ID: 14752799
[TBL] [Abstract][Full Text] [Related]
28. Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases.
Verburg FA; Mäder U; Luster M; Reiners C
Eur J Endocrinol; 2009 Apr; 160(4):619-24. PubMed ID: 19158232
[TBL] [Abstract][Full Text] [Related]
29. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
30. Papillary thyroid cancer incidence in the volcanic area of Sicily.
Pellegriti G; De Vathaire F; Scollo C; Attard M; Giordano C; Arena S; Dardanoni G; Frasca F; Malandrino P; Vermiglio F; Previtera DM; D'Azzò G; Trimarchi F; Vigneri R
J Natl Cancer Inst; 2009 Nov; 101(22):1575-83. PubMed ID: 19893009
[TBL] [Abstract][Full Text] [Related]
31. Defective ciliogenesis in thyroid hürthle cell tumors is associated with increased autophagy.
Lee J; Yi S; Kang YE; Chang JY; Kim JT; Sul HJ; Kim JO; Kim JM; Kim J; Porcelli AM; Kim KS; Shong M
Oncotarget; 2016 Nov; 7(48):79117-79130. PubMed ID: 27816963
[TBL] [Abstract][Full Text] [Related]
32. Restricting ultrasound thyroid fine needle aspiration biopsy by nodule size: which tumors are we missing? A population-based study.
Brito JP; Singh-Ospina N; Gionfriddo MR; Maraka S; Espinosa De Ycaza A; Rodriguez-Gutierrez R; Morris JC; Montori VM; Tuttle RM
Endocrine; 2016 Mar; 51(3):499-505. PubMed ID: 26254791
[TBL] [Abstract][Full Text] [Related]
33. Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria.
Renshaw AA
Cancer; 2002 Oct; 96(5):261-6. PubMed ID: 12378592
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.
Schulten HJ; Salama S; Al-Ahmadi A; Al-Mansouri Z; Mirza Z; Al-Ghamdi K; Al-Hamour OA; Huwait E; Gari M; Al-Qahtani MH; Al-Maghrabi J
Anticancer Res; 2013 Nov; 33(11):4779-84. PubMed ID: 24222113
[TBL] [Abstract][Full Text] [Related]
35. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
Elliott DD; Pitman MB; Bloom L; Faquin WC
Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
[TBL] [Abstract][Full Text] [Related]
36. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
37. Follicular thyroid cancer: minimally invasive tumours can give rise to metastases.
Ban EJ; Andrabi A; Grodski S; Yeung M; McLean C; Serpell J
ANZ J Surg; 2012 Mar; 82(3):136-9. PubMed ID: 22510122
[TBL] [Abstract][Full Text] [Related]
38. Differentiated thyroid cancer and outcome in iodine deficiency.
Gyory F; Balazs G; Nagy EV; Juhasz F; Mezosi E; Szakall S; Math J; Lukacs G
Eur J Surg Oncol; 2004 Apr; 30(3):325-31. PubMed ID: 15028317
[TBL] [Abstract][Full Text] [Related]
39. Five-year change in morphological and functional alterations of the thyroid gland: the Study of Health in Pomerania.
Völzke H; Ittermann T; Albers M; Friedrich N; Nauck M; Below H; Kramer A
Thyroid; 2012 Jul; 22(7):737-46. PubMed ID: 22663551
[TBL] [Abstract][Full Text] [Related]
40. [Histological variants (subtypes) of differentiated thyroid carcinoma].
Abduluakhab M; Mikhaĭlov I; Gavrilov M
Khirurgiia (Sofiia); 1997; 50(3):31-4. PubMed ID: 9739840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
